|
100
|
287
|
4qmzA |
Mst3 in complex with sunitinib |
|
53
|
168
|
4q5eA |
Shigella effector kinase ospg bound to e2-ub ubch7-ub conjugate |
|
87
|
281
|
4qmlA |
Mst3 in complex with amp-pnp |
|
114
|
330
|
4qtcA |
Structure of human haspin (gsg2) in complex with sch772984 revealing the first type-i binding mode |
|
75
|
273
|
4rc4A |
Crystal structure of ser/thr kinase pim1 in complex with mitoxantrone derivatives |
|
88
|
288
|
4qmxA |
Mst3 in complex with saracatinib |
|
83
|
287
|
4qpsA |
Crystal structure of jak3 complexed to n-[3-(6-phenylamino-pyrazin-2-yl)-3h-benzoimidazol-5-yl]-acrylamide |
|
86
|
323
|
4r3rA |
Crystal structures of egfr in complex with mig6 |
|
82
|
286
|
4pdoA |
Structure of ephrin type-a receptor 2 |
|
107
|
403
|
4pl5A |
Crystal structure of murine ire1 in complex with oicr573 inhibitor |
|
84
|
293
|
4p90A |
Crystal structure of the kinase domain of human pak1 in complex with compound 15 |
|
85
|
292
|
4p4cA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
70
|
297
|
4qdeA |
Dcps in complex with covalent inhibitor |
|
88
|
273
|
4px6A |
Syk catalytic domain in complex with a potent pyridopyrimidinone inhibitor |
|
93
|
405
|
4pl3A |
Crystal structure of murine ire1 in complex with mkc9989 inhibitor |
|
119
|
337
|
4pdyA |
Crystal structure of aminoglycoside phosphotransferase from alicyclobacillus acidocaldarius subsp. acidocaldarius dsm 446 |
|
66
|
271
|
4q2aA |
Wnk1: a chloride sensor via autophosphorylation |
|
103
|
347
|
4pteA |
Structure of a carvoxamide compound (15) (n-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide) to gsk3b |
|
84
|
295
|
4p5zA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
159
|
599
|
4oliA |
The pseudokinase/kinase protein from jak-family member tyk2 |
|
79
|
273
|
4q9sA |
Crystal structure of human focal adhesion kinase (fak) bound to compound1 (3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one) |
|
87
|
275
|
4pv0A |
Crystal structure of spleen tyrosine kinase (syk) in complex with an imidazopyrazine inhibitor |
|
76
|
264
|
4pp9A |
Itk kinase domain with compound 1 (n-[1-(3-cyanobenzyl)-1h-pyrazol-4-yl]-2h-indazole-3-carboxamide) |
|
77
|
304
|
4pdpA |
Crystal structure of rad53 kinase domain and scd2 |
|
90
|
296
|
4p5qA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
90
|
291
|
4pmsA |
The structure of trka kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]-1h-pyrrolo[3,2-c]pyridine-2-carboxylic acid |
|
94
|
291
|
4pmmA |
The structure of trka kinase bound to the inhibitor n-(3-cyclopropyl-1-phenyl-1h-pyrazol-5-yl)-2-{4-[3-methoxy-4-(4-methyl-1h-imidazol-1-yl)phenyl]-1h-1,2,3-triazol-1-yl}acetamide |
|
89
|
290
|
4p7eA |
Triazolopyridine compounds as selective jak1 inhibitors: from hit identification to glpg0634 |
|
152
|
465
|
4onaA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1517 |
|
53
|
169
|
4q5hA |
Shigella effector kinase ospg bound to amppnp and e2-ub ubch7-ub conjugate |
|
164
|
504
|
4pniA |
Bovine g protein-coupled receptor kinase 1 in complex with gsk2163632a |
|
77
|
264
|
4prjA |
Aurora a kinase domain with compound 2 (n-[1-(3-cyanobenzyl)-1h-pyrazol-4-yl]-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide) |
|
84
|
278
|
4pf4A |
1.1a x-ray structure of the apo catalytic domain of death-associated protein kinase 1, aa 1-277 |
|
83
|
271
|
4puzA |
Crystal structure of spleen tyrosine kinase (syk) in complex with gs-9973 |
|
84
|
259
|
4pqnA |
Itk kinase domain with compound gne-9822 |
|
81
|
277
|
4p2kA |
Structure of ephrin type-a receptor 2 |
|
78
|
281
|
4otwA |
Her3 pseudokinase domain bound to bosutinib |
|
89
|
346
|
4ptcA |
Structure of a carboxamide compound (3) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to gsk3b |
|
110
|
402
|
4pl4A |
Crystal structure of murine ire1 in complex with oicr464 inhibitor |
|
69
|
300
|
4pdsA |
Crystal structure of rad53 kinase domain and scd2 in complex with amppnp |
|
70
|
274
|
4pwnA |
Crystal structure of active wnk1 kinase |
|
85
|
291
|
4pmtA |
The structure of trka kinase bound to the inhibitor n~4~-(4-morpholin-4-ylphenyl)-n~6~-(pyridin-3-ylmethyl)pyrido[3,2-d]pyrimidine-4,6-diamine |
|
86
|
281
|
4ow8A |
Crystal structure of kinase domain of pkna from mtb |
|
93
|
290
|
4py1A |
Crystal structure of tyk2 in complex with compound 15, 6-((2,5-dimethoxyphenyl)thio)-3-(1-methyl-1h-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
|
99
|
347
|
4ptgA |
Structure of a carboxamine compound (26) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to gsk3b |
|
73
|
227
|
4o81A |
Saicar synthetase (type-1) in complex with adp and amp |
|
103
|
349
|
4n4sA |
A double mutant rat erk2 in complex with a pyrazolo[3,4-d]pyrimidine inhibitor |
|
87
|
298
|
4obpA |
Map4k4 in complex with inhibitor (compound 29), 6-(2-fluoropyridin-4-yl)pyrido[3,2-d]pyrimidin-4-amine |
|
97
|
309
|
4nw6A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27 |
|
81
|
295
|
4oboA |
Map4k4 in complex with inhibitor (compound 22), 6-(3-chlorophenyl)quinazolin-4-amine |
